Key facts
- It has raised $3.5M; the latest was PE Growth/Expansion ($3.5M) in Jun 2025.
- Notable investors include LongueVue Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for KPS Life
- ·The full record, as it builds
Funding rounds
No funding rounds for KPS Life are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About KPS Life
Provider of outsourced clinical trial services to pharmaceutical companies globally. The company's services include clinical monitoring, clinical oversight, clinical trial management, data management, document management, vendor qualification, and medical writing, enabling companies to conduct clinical trials and to avoid unnecessary and often required change orders at reduced costs.
- Sector
- Business Products and Services (B2B)
- HQ
- Malvern, PA, United States
- Founded
- 2006
- Employees
- 300
- Website
- kpslife.com/
- Ownership
- Privately Held (backing)
KPS Life doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in KPS Life shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on KPS Life in its N-PORT filings yet. We sweep new filings monthly.